Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Stock SIPAutomate your investments in this
Performance
Open
351.20Prev. Close
351.85Volume
0Total traded value
NAUpper Circuit
387.00Lower Circuit
316.70Fundamentals
| Market Cap | ₹47,028Cr |
| ROE | 4.68% |
| P/E Ratio(TTM) | 71.64 |
| EPS(TTM) | 4.91 |
| P/B Ratio | 1.80 |
| Dividend Yield | 0.13% |
| Industry P/E | 34.98 |
| Book Value | 195.54 |
| Debt to Equity | 0.85 |
| Face Value | 5 |
Understand Fundamentals
Financials
About Biocon
Biocon Group is a global biopharmaceutical company dedicated to delivering high-quality, affordable medicines like generics and biosimilars to patients around the world. The company's core belief is that the right to health begins with access to affordable medicines, which is fundamental to creating a lasting global impact. Through its generics and biosimilars segments, the company has benefited over 21.2 million patients.;
| Parent Organisation | Biocon Limited |
| Managing Director | Mr. Siddharth Mittal |
| NSE Symbol | BIOCON |
Shareholding Pattern
Jun '24
Sep '24
Dec '24
Mar '25
Jun '25
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Anthem Biosciences | NA (0.00%) | 96.07 | ||
| Onesource Specialty Pharma | NA (0.00%) | 309.15 | ||
| Advanced Enzyme Technologies | NA (0.00%) | 24.55 | ||
| Panacea Biotec | NA (0.00%) | 244.53 |